Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03780387 · ClinicalTrials.gov registry record · Early Phase 1
Identification of Allergic Asthmatics Reactive to Felis Catus (Cat Hair) Allergen Inhalation
A Early Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 1
- Enrollment target
NCT03780387 is a Early Phase 1 study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 1 participants.
The verdict
NCT03780387, a Early Phase 1 study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study is designed to identify Felis Catus, or cat hair, sensitive asthmatics who demonstrate a late phase asthmatic response after cat hair inhalation. These subjects may be invited to participate in a planned future study investigating novel asthma treatments.
Interventions
- BIOLOGICAL Felis Catus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-04-16 |
| Est. Completion | 2019-11-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03780387
The ClinicalTrials.gov registry entry for NCT03780387 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Felis Catus is the first listed.
NCT03780387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03780387 about?
NCT03780387 is a clinical study titled "Identification of Allergic Asthmatics Reactive to Felis Catus (Cat Hair) Allergen Inhalation". This study is designed to identify Felis Catus, or cat hair, sensitive asthmatics who demonstrate a late phase asthmatic response after cat hair inhalation. These subjects may be invited to participate in a planned future study investigating novel asthma treatments.
What is the current status of trial NCT03780387?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 1 participants. The study started on 2019-04-16. Estimated completion is 2019-11-11.
What interventions are being tested in trial NCT03780387?
The interventions under investigation include: Felis Catus (BIOLOGICAL).
Who is sponsoring clinical trial NCT03780387?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.